Molecular Imaging of HER2 Expression in Breast Cancer Using Technetium-99m-labelled DARPin HE3-G3 (99mTc-HE3-G3)
Condition: Primary Breast Cancer Intervention: Diagnostic Test: SPECT Sponsors: Tomsk National Research Medical Center of the Russian Academy of Sciences; Institute of Bioorganic Chemistry, Russian Academy of Sciences; Uppsala University Enrolling by invitation
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Academies | Breast Cancer | Cancer | Cancer & Oncology | Chemistry | HER2 | Research | Russia Health | SPECT